Meeting
2014 ASCO Annual Meeting
Prophylactic ciprofloxacin to prevent febrile neutropenia in adjuvant breast cancer patients receiving docetaxel (nonanthracycline) regimens.
Authors
Meena Okera
Adelaide Cancer Centre, Adelaide, Australia
Meena Okera , Ben W. Stevenson , Brian N. Stein , Nimit Singhal , Francis Parnis , Kerry A. Cheong , Carolyn L. Bampton , Sarwan K. Bishnoi , Dusan Kotasek
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1036)
DOI
10.1200/jco.2014.32.15_suppl.1036
Abstract #
1036
Poster Bd #
129
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Association of primary prophylactic (PP) granulocyte-colony stimulating factor (G-CSF) use with chemotherapy dose modifications and relative dose intensity (RDI) among breast cancer patients receiving high-risk regimens for febrile neutropenia (FN).
First Author: Jaime Shaw
Poster
2012 Breast Cancer Symposium
Adjuvant chemotherapy for early-stage breast cancer: Choice of regimen and associated hematologic toxicities in a metropolitan Australian hospital.
First Author: Katherine Lovat
Poster
2011 Breast Cancer Symposium
Utilization of pegfilgrastim in adjuvant chemotherapy regimens for breast cancer in the community.
First Author: D. A. Patt
Poster
2015 Breast Cancer Symposium
Review of trends in adjuvant chemotherapy regimens in breast cancer over 10 year period at Yale New Haven Hospital (YNHH).
First Author: Rosana Gnanajothy